Comparison of Subconjunctival Aflibercept and Betamethasone for the Treatment of Formed Corneal Neovascularization in a Rabbit Model
Author:
Publisher
S. Karger AG
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology,General Medicine
Reference23 articles.
1. Sella R, Gal-Or O, Livny E, Dachbash M, Nisgav Y, Weinberger D, et al. Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model. Exp Eye Res. 2016 May;146:224–32.
2. Gal-Or O, Livny E, Sella R, Nisgav Y, Weinberger D, Livnat T, et al. Efficacy of subconjunctival aflibercept versus bevacizumab for prevention of corneal neovascularization in a rat model. Cornea. 2016 Jul;35(7):991–6.
3. Cursiefen C, Colin J, Dana R, Diaz-Llopis M, Faraj LA, Garcia-Delpech S, et al. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol. 2012 Jan;96(1):3–9.
4. Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology. 2010 Jul;117(7):1300–5.e7.
5. Krizova D, Vokrojova M, Liehneova K, Studeny P. Treatment of corneal neovascularization using anti-VEGF Bevacizumab. J Ophthalmol. 2014;2014:178132.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns;Frontiers in Medicine;2023-06-22
2. Overactivation of Norepinephrine–β2-Adrenergic Receptor Axis Promotes Corneal Neovascularization;Investigative Opthalmology & Visual Science;2023-03-10
3. Nanoparticle-mediated corneal neovascularization treatments: Toward new generation of drug delivery systems;Chinese Chemical Letters;2023-03
4. Successful Regression of Newly Formed Corneal Neovascularization by Subconjunctival Injection of Bevacizumab in Patients with Chemical Burns;2022-08-25
5. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization;Theranostics;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3